News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,351 Results
Type
Article (87420)
Company Profile (739)
Press Release (770174)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (232769)
Career Advice (4143)
Deals (39874)
Drug Delivery (144)
Drug Development (91179)
Employer Resources (205)
FDA (18255)
Job Trends (17422)
News (396857)
Policy (39845)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3002)
Academic (1)
Accelerated approval (31)
Adcomms (30)
Allergies (120)
Alliances (56794)
ALS (154)
Alzheimer's disease (1751)
Antibody-drug conjugate (ADC) (312)
Approvals (18368)
Artificial intelligence (469)
Autoimmune disease (160)
Automation (31)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (457)
Bladder cancer (145)
Brain cancer (52)
Breast cancer (539)
Cancer (4279)
Cardiovascular disease (301)
Career advice (3568)
Career pathing (41)
CAR-T (291)
CDC (36)
Celiac Disease (1)
Cell therapy (763)
Cervical cancer (29)
Clinical research (76114)
Collaboration (1607)
Company closure (4)
Compensation (998)
Complete response letters (64)
COVID-19 (2927)
CRISPR (85)
C-suite (737)
Cystic fibrosis (143)
Data (5419)
Decentralized trials (2)
Denatured (73)
Depression (114)
Diabetes (342)
Diagnostics (6977)
Digital health (23)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (252)
Drug pricing (161)
Drug shortages (19)
Duchenne muscular dystrophy (200)
Earnings (98003)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (132818)
Executive appointments (825)
FDA (20626)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1271)
Gene editing (183)
Generative AI (46)
Gene therapy (606)
GLP-1 (931)
Government (5324)
Grass and pollen (4)
Guidances (276)
Healthcare (20778)
HIV (43)
Huntington's disease (46)
IgA nephropathy (79)
Immunology and inflammation (267)
Immuno-oncology (59)
Indications (81)
Infectious disease (3147)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (95)
Intellectual property (198)
Interviews (816)
IPO (17808)
IRA (45)
Job creations (5198)
Job search strategy (2866)
JPM (66)
Kidney cancer (16)
Labor market (92)
Layoffs (639)
Leadership (37)
Legal (10091)
Liver cancer (87)
Longevity (13)
Lung cancer (585)
Lymphoma (331)
Machine learning (41)
Management (66)
Manufacturing (715)
MASH (159)
Medical device (14421)
Medtech (14451)
Mergers & acquisitions (22745)
Metabolic disorders (1066)
Multiple sclerosis (154)
NASH (22)
Neurodegenerative disease (330)
Neuropsychiatric disorders (79)
Neuroscience (2900)
Neurotech (1)
NextGen: Class of 2026 (7686)
Non-profit (5080)
Now hiring (65)
Obesity (522)
Opinion (326)
Ovarian cancer (150)
Pain (153)
Pancreatic cancer (170)
Parkinson's disease (260)
Partnered (33)
Patents (396)
Patient recruitment (418)
Peanut (56)
People (66284)
Pharmaceutical (133)
Pharmacy benefit managers (20)
Phase 1 (23597)
Phase 2 (33126)
Phase 3 (24816)
Pipeline (4313)
Policy (283)
Postmarket research (3544)
Preclinical (10586)
Press Release (72)
Prostate cancer (203)
Psychedelics (51)
Radiopharmaceuticals (278)
Rare diseases (797)
Real estate (7423)
Recruiting (80)
Regulatory (28239)
Reports (63)
Research institute (2695)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (21)
RSV (63)
Schizophrenia (139)
Series A (225)
Series B (161)
Service/supplier (25)
Sickle cell disease (85)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4323)
State (2)
Stomach cancer (14)
Supply chain (74)
Tariffs (76)
The Weekly (122)
Vaccines (999)
Venture capital (91)
Weight loss (339)
Women's health (71)
Worklife (22)
Date
Today (80)
Last 7 days (449)
Last 30 days (1677)
Last 365 days (25311)
2026 (2458)
2025 (25543)
2024 (34032)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (85)
Alaska (6)
Arizona (288)
Arkansas (8)
Asia (51126)
Australia (9003)
California (9730)
Canada (2478)
China (1059)
Colorado (306)
Connecticut (390)
Delaware (295)
Europe (116916)
Florida (1258)
Georgia (253)
Hawaii (4)
Idaho (65)
Illinois (652)
India (56)
Indiana (447)
Iowa (21)
Japan (341)
Kansas (133)
Kentucky (25)
Louisiana (14)
Maine (59)
Maryland (1257)
Massachusetts (7317)
Michigan (244)
Minnesota (453)
Mississippi (5)
Missouri (79)
Montana (28)
Nebraska (29)
Nevada (106)
New Hampshire (57)
New Jersey (2554)
New Mexico (29)
New York (2555)
North Carolina (1412)
North Dakota (9)
Northern California (4777)
Ohio (257)
Oklahoma (18)
Oregon (51)
Pennsylvania (1874)
Puerto Rico (22)
Rhode Island (33)
South America (1658)
South Carolina (13)
South Dakota (1)
Southern California (3755)
Tennessee (58)
Texas (1363)
United States (33830)
Utah (209)
Vermont (1)
Virginia (168)
Washington D.C. (54)
Washington State (818)
West Virginia (2)
Wisconsin (82)
858,351 Results for "tourmaline bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novartis completes acquisition of Tourmaline Bio
October 29, 2025
·
6 min read
Press Releases
Novartis announces expiration of Tourmaline Bio tender offer
October 28, 2025
·
5 min read
Press Releases
Novartis announces commencement of tender offer to acquire Tourmaline Bio
September 30, 2025
·
9 min read
Press Releases
Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG
September 9, 2025
·
10 min read
Press Releases
Novartis announces expiration of Hart-Scott-Rodino waiting period of Tourmaline Bio tender offer
October 22, 2025
·
7 min read
Press Releases
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
September 9, 2025
·
10 min read
Press Releases
Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 13, 2025
·
10 min read
Press Releases
Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress
September 1, 2025
·
7 min read
Pharm Country
Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
Tourmaline Bio, Inc. today announced that Sandeep Kulkarni, CEO, is expected to participate in the following investor conference.
May 23, 2024
·
1 min read
Business
Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
Tourmaline Bio, Inc. today announced the promotion of Ryan Robinson, CPA, to Chief Financial Officer and Treasurer, effective June 25, 2024.
June 27, 2024
·
4 min read
1 of 85,836
Next
